Clinical features and molecular genetics of Von Hippel-Lindau disease

References

• Von Hippel E. Uber eine sehr seltene erkrankung der netzhaut. Albrecht von Graeves Arch Ophthalmol 1904; 59: 83
   Google Scholar
• Von Hippel E. Die anatomische Grundlage der von mir beschreiben ‘Uber eine sehr seltene erkrankung der netzhaut’. Albrecht von Graeves Arch Ophthalmol 1904; 59: 83
   Google Scholar
• Lindau A. Studien uber kleinhirncysten. Bau, Pathogenese und Beziehungen zur angiomatosis retinae. Acta Pathol Microbiol Scand 1926; 77, Suppl 1
   Google Scholar
• Maher E R, Iselius L, Yates J R. Von Hippel-Lindau disease: a genetic study. J Med Genet 1991; 28: 443–447
   PubMed Web of Science ®Google Scholar
• Maher E R, Yates J R. Familial renal cell carcinoma: clinical and molecular genetic aspects. Br J Cancer 1991; 63: 176–179
   PubMedGoogle Scholar
• Duke-Elder S. System of Ophthalmology, Volume X. Henry Kimpton. 1967; 738–754
   Google Scholar
• Maher E R, Yates J R, Harries R, Benjamin C, Harris R, Moore A T, Ferguson-Smith M A. Clinical features and natural history of von Hippel-Lindau disease. Q J Med 1990; 77: 1151–1163
   PubMedGoogle Scholar
• Green J S, Bowmer M I, Johnson G J. Von Hippel-Lindau disease in a Newfoundland kindred. Can Med Assoc J 1986; 134: 133–138
   Web of Science ®Google Scholar
• Lamiell J M, Salazar F G, Hsia Y E. Von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine 1989; 68: 1–29
   PubMed Web of Science ®Google Scholar
• Glenn G M, Choyke P, Zbar B, Linehan W M. Von Hippel-Lindau disease: clinical review and molecular genetics. Probl Urol 1990; 4: 312–330
   Google Scholar
• Resche F, Moisan J P, Mantoura J. Haemangioblastoma, haemangio-blastomatosis, and von Hippel-Lindau disease. Adv Tech Stand Neurosurg 1993; 20: 197–304
   PubMedGoogle Scholar
• Richard S, Chauveau D, Chretien Y. Renal lesions and pheochromocytoma in von Hippel-Lindau disease. Adv Nephrol 1994; 23: 1–27
   PubMedGoogle Scholar
• Melmon K L, Rosen S W. Lindau's disease. Am J Med 1964; 36: 595–617
   PubMed Web of Science ®Google Scholar
• Moore A T, Maher E R, Rosen P, Gregor Z, Bird A C. Ophthalmological screening for von Hippel Lindau disease. Eye 1991; 5: 723–728
   PubMedGoogle Scholar
• Guerry D, Wiesinger H, Ham WT, Jr. Photocoagulation of the retina: report of a successfully treated case of angiomatosis retinae. Am J Ophthalmol 1958; 46: 463
   PubMedGoogle Scholar
• Gass J DM. Cavernous haemangioma of the retina. Am J Ophthalmol 1971; 71: 799
   PubMedGoogle Scholar
• Goldberg M F, Koenig S. Argon laser treatment of von Hippel Lindau retinal angiomas. I. Clinical and angiographic findings. Arch Ophth 1974; 92: 121
   PubMedGoogle Scholar
• Apple D J, Goldberg M F, Wyhinny G J. Argon laser treatment of von Hippel Lindau retinal angiomas II. Histopathology of treated lesions. Arch Ophthalmol 1974; 92: 126
   PubMedGoogle Scholar
• Lane C M, Turner G, Gregor Z J, Bird A C. Laser treatment of retinal angiomatosis. Eye 1989; 3: 33
   PubMed Web of Science ®Google Scholar
• Welch R B. Von Hippel Lindau disease: the recognition and treatment of early angiomatosis retinae and the use of cryosurgery as an adjunct to therapy. Trans Am Ophthalmol Soc 1970; 68: 367
   PubMedGoogle Scholar
• Ridley M, Green J, Johnson G. Retinal angiomatosis: the ocular manifestations of von Hippel Lindau disease. Can J Ophthalmol 1986; 21: 276
   PubMed Web of Science ®Google Scholar
• Annesley W H, Leonard B C, Shields J A, Tasman W S. Fifteen year review of treated cases of retinal angiomatosis. Trans Am Acad Ophthalmol Otolaryngol 1977; 83: 446
   Google Scholar
• Plowman P N, Harnett A N. Radiotherapy in benign orbital disease. I. Complicated ocular angiomas. Br J Ophthalmol 1988; 72: 286
   PubMedGoogle Scholar
• Balazs E, Berta A, Rosza L, Kolosvari L, Rigo G. Hemodynamic changes after ruthenium irradiation of Hippel's angiomatosis. Ophthalmologica 1990; 200: 128
   PubMed Web of Science ®Google Scholar
• Peyman G A, Redman K R, Mottw-Lipa I, Flood T. Treatment of large von Hippel tumours by eye-ball resection. Ophthalmology 1983; 90: 840
   PubMed Web of Science ®Google Scholar
• Whitson J T, Welsh R B, Green W R. Von Hippel Lindau disease: case report of a patient with spontaneous regression of a retinal angioma. Retina 1986; 6: 253–259
   PubMed Web of Science ®Google Scholar
• Seizinger B R, Rouleau G A, Ozelius L J. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 1988; 332: 268–269
   PubMed Web of Science ®Google Scholar
• Hosoe S, Brauch H, Latif F. Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3. Genomics 1990; 8: 634–640
   PubMed Web of Science ®Google Scholar
• Maher E R, Bentley E, Yates J RW. Localization of the gene for von Hippel-Lindau disease to a small region of chromosome 3p by genetic linkage analysis. Genomics 1991; 10: 957–960
   PubMedGoogle Scholar
• Seizinger B R, Smith D I, Filling-Katz M R. Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Landau disease. Proc Natl Acad Sci USA 1991; 88: 2864–2868
   PubMed Web of Science ®Google Scholar
• Crossey P A, Maher E R, Jones M H. Genetic linkage between von Hippel-Lindau disease and three microsatellite polymorphisms refines the localisation of the vhl locus. Hum Mol Genet 1993; 2: 279–282
   PubMedGoogle Scholar
• Richards F M, Phipps M E, Latif F. Mapping the Von Hippel-Lindau disease tumour suppressor gene: identification of germline deletions by pulsed field gel electrophoresis. Hum Mol Genet 1993; 2: 879–882
   PubMedGoogle Scholar
• Maher E R, Bentley E, Payne S J. Presymptomatic diagnosis of von Hippel-Lindau disease with flanking dna markers. J Med Genet 1992; 29: 902–905
   PubMedGoogle Scholar
• Glenn G M, Linehan W M, Hosoe S. Screening for von Hippel-Lindau disease by dna polymorphism analysis. J Am Med Assoc 1992; 267: 1226–1231
   PubMed Web of Science ®Google Scholar
• Latif F, Tory K, Gnarra J. Identification of the von Hippel-Lindau disease tumour suppressor gene. Science 1993; 260: 1317–1320
   PubMed Web of Science ®Google Scholar
• Richards F M, Crossey P A, Phipps M E. Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene. Hum Mol Genet 1994; 3: 595–598
   PubMed Web of Science ®Google Scholar
• Crossey P A, Richards F M, Foster K. Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet 1994; 3: 1303–1308
   PubMed Web of Science ®Google Scholar
• Chen F, Kishida T, Yao M. Germ line mutations in the von Hippel Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat 1995; 5: 66–75
   PubMed Web of Science ®Google Scholar
• Whaley J S, Naglich J, Gelbert L. Germ-line mutations in the von Hippel Lindau tumor-suppressor gene are similar to somatic von Hippel Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 1994; 55: 1092–1102
   PubMed Web of Science ®Google Scholar
• Goodrich D W, Lee W H. Molecular characterization of the retinoblastoma susceptibility gene (Review). Biochem Biophys Acta 1993; 1155: 43–61
   PubMed Web of Science ®Google Scholar
• Gnarra J R, Tory K, Weng Y. Mutations of the vhl tumour suppressor gene in renal carcinoma. Nat Genet 1994; 7: 85–90
   PubMed Web of Science ®Google Scholar
• Shuin T, Kondo K, Torigoe S. Frequent somatic mutations and loss of heterozygosity of the von Hippel Lindau tumour suppressor gene in human renal cell carcinoma. Cancer Res 1994; 54: 2852–2855
   PubMed Web of Science ®Google Scholar
• Foster K, Prowse A, Van der Berg A. Somatic mutations of the von Hippel Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Hum Mol Genet 1994; 3: 2169–2173
   PubMed Web of Science ®Google Scholar